Showing results (101-110 of 1,607) with videos related to

Sort By:
Pageof 161
JAMA Oncology|October 20, 2022
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical TrialJoshua D Palmer, Brett G Klamer, Karla V Ballman, et al.
JAMA Oncology|February 25, 2021
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid TumorsErin F Cobain, Yi-Mi Wu, Pankaj Vats, et al.
JAMA Oncology|February 25, 2021
Current Treatment Strategies and Future Directions for Extrapulmonary Neuroendocrine Carcinomas: A ReviewJohannes Stelwagen, Elisabeth G E de Vries, Annemiek M E Walenkamp
JAMA Oncology|August 9, 2019
Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast CancerNancy Y Yu, Adina Iftimi, Christina Yau, et al.
JAMA Oncology|September 20, 2019
Association of Early Palliative Care Use With Survival and Place of Death Among Patients With Advanced Lung Cancer Receiving Care in the Veterans Health AdministrationDonald R Sullivan, Benjamin Chan, Jodi A Lapidus, et al.
JAMA Oncology|September 20, 2019
Overall Mortality After Diagnosis of Breast Cancer in Men vs WomenFei Wang, Xiang Shu, Ingrid Meszoely, et al.
JAMA Oncology|September 27, 2019
Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical TrialAmylou C Dueck, Howard I Scher, Antonia V Bennett, et al.
JAMA Oncology|September 27, 2019
The Value of Progression-Free Survival as a Treatment End Point Among Patients With Advanced Cancer: A Systematic Review and Qualitative Assessment of the LiteratureMichael J Raphael, Andrew Robinson, Christopher M Booth, et al.
JAMA Oncology|November 2, 2018
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical TrialLillian L Siu, Caroline Even, Ricard Mesía, et al.
JAMA Oncology|December 16, 2021
Association of Antiparietal Cell and Anti-Intrinsic Factor Antibodies With Risk of Gastric CancerMinkyo Song, M Constanza Camargo, Hormuzd A Katki, et al.
Pageof 161